Marshall Wace, LLP Immuneering Corp Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
A detailed history of Marshall Wace, LLP transactions in Immuneering Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 573,864 shares of IMRX stock, worth $3.62 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
573,864
Previous 807,969
28.97%
Holding current value
$3.62 Million
Previous $1.23 Million
57.41%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IMRX
# of Institutions
40Shares Held
3.78MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$6.66 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$3.36 Million0.0% of portfolio
-
Southport Management, L.L.C. Wilson, WY245KShares$1.54 Million4.03% of portfolio
-
Geode Capital Management, LLC Boston, MA230KShares$1.45 Million0.0% of portfolio
-
Morgan Stanley New York, NY201KShares$1.27 Million0.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $166M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...